Erythropoiesis-Stimulating Agents and the Risk of Vision-Threatening Diabetic Retinopathy.
Jonathan C TsuiKeirnan WillettJordana B CohenYinxi YuBrian L VanderBeekPublished in: Ophthalmic epidemiology (2023)
ESAs are associated with higher risks for VTDR and DME, but not PDR. Those studying ESAs as adjunctive therapy for DR should be cautious of possible unintended effects.